UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - BIOTIME INC ownership

BIOTIME INC's ticker is BTX and the CUSIP is 09066L105. A total of 107 filers reported holding BIOTIME INC in Q2 2018. The put-call ratio across all filers is 2.38 and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC ownership history of BIOTIME INC
ValueSharesWeighting
Q1 2019$60,940,000
+84.4%
46,519
+28.5%
0.00%
Q4 2018$33,052,000
-61.1%
36,2010.0%0.00%
Q3 2018$85,072,000
+14.1%
36,2010.0%0.00%
Q2 2018$74,574,000
-23.4%
36,2010.0%0.00%
Q1 2018$97,381,000
+304.4%
36,201
+223.2%
0.00%
Q4 2017$24,082,00011,2010.00%
Other shareholders
BIOTIME INC shareholders Q2 2018
NameSharesValueWeighting ↓
BROADWOOD CAPITAL INC 17,832,785$66,516,00013.57%
Manatuck Hill Partners, LLC 1,282,050$4,782,0001.04%
Consonance Capital Management LP 1,602,550$5,978,0000.77%
Destination Wealth Management 594,645$2,218,0000.22%
Granite Point Capital Management, L.P. 115,000$429,0000.20%
Artal Group S.A. 1,282,050$4,782,0000.17%
ALBION FINANCIAL GROUP /UT 23,085$86,0000.02%
WILLIAMS JONES & ASSOCIATES LLC 55,000$205,0000.01%
Veritable, L.P. 82,625$308,0000.01%
Peachtree Investment Advisors, Inc. 2,000$7,0000.01%
View complete list of BIOTIME INC shareholders